Ciena R&D chief sells 498 shares in 10b5-1 plan
CIENA’s EVP & Chief R&D Officer reported Rule 10b5-1 sales totaling 498 CIEN shares over two days.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CIENA CORP (CIEN) executive Dino DiPerna, EVP & Chief R&D Officer, reported open-market sales of company common stock under a Rule 10b5-1 trading plan. He sold 249 shares on September 15, 2026 at $324.86 per share and 249 shares on September 16, 2026 at $350.00 per share. A footnote states that the shares reported on this Form 4 include unvested Restricted Stock Units and Performance Stock Units.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 249 | $350.00 | $87K |
| Sale | Common Stock F1, F2 | 249 | $324.86 | $81K |
Footnotes (2)
- F1. Sales were affected pursuant to Rule 10b5-1 trading plan dated 6/10/2026.
- F2. Shares reported include unvested Restricted Stock Units (RSUs) and Performance Stock Units (PSUs).
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Restricted Stock Units (RSUs) financial
Performance Stock Units (PSUs) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CIEN executive Dino DiPerna report?
Were Dino DiPerna’s CIEN stock sales under a Rule 10b5-1 plan?
What is Dino DiPerna’s role at CIENA CORP (CIEN)?
Do the reported CIEN holdings include RSUs or PSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.